Editor’s Note: Happy Monday Bold Profits Nation! Paul here. I told you exciting things were coming to your Market Talk. And we’re getting the ball rolling today. Amber and (introducing her amazing furry sidekick and Profits Unlimited staple Alex) jump right into one big opportunity we’re watching today.
It’s a hot market and she’ll highlight the huge success we’ve seen by investing in it — including a 400% gain on a biotech company. And tomorrow, I’m going to be releasing a new trade that I think will eclipse that 400% winner. Click here to make sure YOU get access to this live buy alert first.
And keep reading for your Market Talk 2.0!
— Paul Mampilly
America 2.0 is going public!
Right now, the market’s filled with opportunities to get into stocks hitting the market for the first time.
Investing in a company’s initial public offerings (IPOs) is one of the best ways to lock in massive gains.
And one of the most promising IPO sectors is biotech. Biotech IPOs are averaging an 80% return from their offer prices!
We’re seeing signs pointing to a robust IPO market unfolding now, which is big news for America 2.0 investors like you.
In today’s Market Talk, I’ll give you a peek behind the curtain at our internal investment call when we talk about the big IPO opportunities brewing this year.
If you want the best chance at getting into these groundbreaking gainers and want to know what the Bold Profits team is seeing that shows us why now is the time to buy biotech IPOs, watch Market Talk 2.0:
Regards,
Amber Lancaster
Director of Investment Research, Banyan Hill Publishing
P.S. Are you excited for Market Talk 2.0? We’ll be checking in on you frequently to make sure you get the very best from our team. And you can always email us at boldprofitsdaily@banyanhill.com. Alex and I will be watching the inbox for any stories, suggestions or questions you have!
